• Thumbnail for Janssen COVID-19 vaccine
    Janssen Ad26.COV2.S (COVID-19) vaccine (Guidance). World Health Organization. 15 June 2021. WHO/2019-nCoV/vaccines/SAGE_recommendation/Ad26.COV2.S/2021.2...
    142 KB (11,316 words) - 14:22, 4 February 2024
  • S. destroyer tender Search for "ad26"  or "ad-26" on Wikipedia. 26 Air Defence Regiment (India) (26.AD) Ad26.COV2.S, COVID-19 vaccine by Janssen Pharmaceutical...
    629 bytes (122 words) - 22:44, 11 July 2021
  • known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein...
    318 KB (19,351 words) - 20:00, 21 April 2024
  • Thumbnail for Viral vector vaccine
    With the increasing prevalence of adenoviral vaccines, two vaccines, Ad26.COV2.S and ChadOx1-nCoV-19, have been linked to the rare clotting disorder,...
    32 KB (3,317 words) - 14:21, 24 January 2024
  • Thumbnail for South African Health Products Regulatory Authority
    The South African Health Products Regulatory Authority (SAHPRA) is the organisation in charge of regulating the use of all Health Products throughout the...
    7 KB (567 words) - 12:25, 27 September 2023
  • Thumbnail for Convidecia
    similar to other viral vector vaccines like AZD1222, Gam-COVID-Vac, and Ad26.COV2.S. Its single-dose regimen and normal refrigerator storage requirement...
    36 KB (3,379 words) - 00:52, 31 December 2023
  • Study of Ad26.COV2.S in Adults". 4 August 2020. Archived from the original on 16 September 2020. Retrieved 23 August 2020. "A Study of Ad26.COV2.S for the...
    192 KB (21,930 words) - 19:29, 15 April 2024
  • Thumbnail for History of COVID-19 vaccine development
    granted a provisional determination in relation to its COVID‑19 vaccine, Ad26.COV2.S, in November 2020. On 24 January 2021, the TGA granted provisional approval...
    122 KB (11,028 words) - 02:32, 27 January 2024
  • Thumbnail for SARS-CoV-2 Beta variant
    trials. In January, Johnson & Johnson, which held trials for its Janssen (Ad26.COV2.S) vaccine in South Africa, reported the level of protection against moderate...
    72 KB (6,070 words) - 06:39, 3 February 2024
  • by the government. 29 January – COVID-19 in the UK: A fourth vaccine, Ad26.COV2.S, is shown to be 66% effective against the virus in a one-dose regimen...
    347 KB (33,588 words) - 08:02, 5 April 2024